These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
280 related items for PubMed ID: 31650430
1. Simultaneous Evaluation of Dissolution and Permeation of Oral Drug Solid Formulations for Predicting Absorption Rate-Limiting Factors and In Vitro-In Vivo Correlations: Case Study Using a Poorly Soluble Weakly Basic Drug. Li Z, He X, Tian S, Feng G, Huang C, Xun M, Wu Z, Wang Y. AAPS PharmSciTech; 2019 Oct 24; 20(8):321. PubMed ID: 31650430 [Abstract] [Full Text] [Related]
3. In vitro-in vivo correlations for three different commercial immediate-release indapamide tablets. Yaro P, He X, Liu W, Xun M, Ma Y, Li Z, Shi X. Drug Dev Ind Pharm; 2014 Dec 24; 40(12):1670-6. PubMed ID: 24102615 [Abstract] [Full Text] [Related]
6. Development of a bionic system for the simultaneous prediction of the release/absorption characteristics of enteric-coated formulations. Liu W, He X, Li Z, Gao X, Ma Y, Xun M, Liu C. Pharm Res; 2013 Feb 24; 30(2):596-605. PubMed ID: 23135820 [Abstract] [Full Text] [Related]
7. Application of an In Vitro Dissolution/Permeation System to Early Screening of Oral Formulations of Poorly Soluble, Weakly Basic Drugs Containing an Acidic pH-Modifier. Mizoguchi M, Kataoka M, Yokoyama K, Aihara R, Wada K, Yamashita S. J Pharm Sci; 2018 Sep 24; 107(9):2404-2410. PubMed ID: 29802932 [Abstract] [Full Text] [Related]
8. Advantage of the Dissolution/Permeation System for Estimating Oral Absorption of Drug Candidates in the Drug Discovery Stage. Miyaji Y, Fujii Y, Takeyama S, Kawai Y, Kataoka M, Takahashi M, Yamashita S. Mol Pharm; 2016 May 02; 13(5):1564-74. PubMed ID: 27031624 [Abstract] [Full Text] [Related]
9. Identify super quality markers from prototype-based pharmacokinetic markers of Tangzhiqing tablet (TZQ) based on in vitro dissolution/ permeation and in vivo absorption correlations. Li Z, Liu J, Li Y, Du X, Li Y, Wang R, Lv C, He X, Wang B, Huang Y, Zhang D. Phytomedicine; 2018 Jun 01; 45():59-67. PubMed ID: 29685365 [Abstract] [Full Text] [Related]
10. IVIVC in oral absorption for fenofibrate immediate release tablets using a dissolution/permeation system. Buch P, Langguth P, Kataoka M, Yamashita S. J Pharm Sci; 2009 Jun 01; 98(6):2001-9. PubMed ID: 18855916 [Abstract] [Full Text] [Related]
16. Application of an in vitro DDASS to evaluate oral absorption of two chemicals simultaneously: establishment of a level A in vitro-in vivo correlation. Hou J, He X, Xu X, Shi X, Xu Y, Liu C. Drug Dev Ind Pharm; 2012 Nov 01; 38(11):1305-12. PubMed ID: 22296178 [Abstract] [Full Text] [Related]
18. Analysis of the enhanced oral bioavailability of fenofibrate lipid formulations in fasted humans using an in vitro-in silico-in vivo approach. Fei Y, Kostewicz ES, Sheu MT, Dressman JB. Eur J Pharm Biopharm; 2013 Nov 01; 85(3 Pt B):1274-84. PubMed ID: 23500116 [Abstract] [Full Text] [Related]
19. Combining in vitro dissolution/permeation with microdialysis sampling: Capabilities and limitations for biopharmaceutical assessments of supersaturating drug formulations. Holzem FL, Jensen IH, Petrig Schaffland J, Stillhart C, Brandl M, Bauer-Brandl A. Eur J Pharm Sci; 2023 Sep 01; 188():106533. PubMed ID: 37480963 [Abstract] [Full Text] [Related]